| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Century Therapeutics, Inc. | Director | Stock Option (right to buy) | 44,000 | 12 Jun 2025 | Direct | ||
| Graphite Bio, Inc. | Director | Stock Option (right to buy) | 20,000 | 19 Jul 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 18:25 |
| IPSC | Century Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:49 |
| LENZ | Graphite Bio, Inc. | 19 Jul 2023 | 1 | $0 | 4 | Director | 21 Jul 2023, 17:05 |
| IPSC | Century Therapeutics, Inc. | 27 Jun 2023 | 1 | $0 | 4 | Director | 29 Jun 2023, 16:23 |
| LENZ | Graphite Bio, Inc. | 21 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 17:36 |
| IPSC | Century Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:21 |
| LENZ | Graphite Bio, Inc. | 24 Jun 2021 | 1 | $0 | 4 | Director | 28 Jun 2021, 20:00 |
| LENZ | Graphite Bio, Inc. | 24 Jun 2021 | 0 | $0 | 3 | Director | 24 Jun 2021, 21:19 |
| IPSC | Century Therapeutics, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 16:32 |
| IPSC | Century Therapeutics, Inc. | 17 Jun 2021 | 0 | $0 | 3 | Director | 17 Jun 2021, 17:04 |